文献速递心脏核医学放射性药物与辐射防护

以111In-DANBIRT靶向炎症细胞LFA-1的动脉粥样硬化显像

Imaging of atherosclerosis, targeting LFA-1 on inflammatory cells with 111In-DANBIRT.
PubMed 文献 · J Nucl Cardiol · 2018-03-13

本研究评估新型放射性配体111In-DANBIRT(靶向炎症细胞LFA-1)在ApoE-/-小鼠动脉粥样硬化斑块炎症显像中的应用,SPECT/CT可见主动脉弓局灶性摄取,平均靶本比1.7±0.5,离体SPECT/CT靶本比最高达11.5,摄取与斑块脂质染色及CD68、LFA-1阳性炎症细胞共定位;人颈动脉内膜切除标本离体孵育亦显示异质性斑块摄取并与CD68、LFA-1表达细胞共定位。

要点

  • ApoE-/-小鼠注射111In-DANBIRT后3小时SPECT/CT可见主动脉弓局灶性摄取,平均靶本比1.7±0.5。
  • 离体SPECT/CT验证靶本比最高达11.5(范围2.6至11.5),摄取与油红O脂质染色斑块共定位。
  • 人颈动脉内膜切除标本离体孵育显示异质性斑块摄取,并与CD68和LFA-1表达细胞共定位。

核心结论

  • 结果表明放射性标记的DANBIRT有潜力作为无创评估动脉粥样硬化炎症的相关显像放射性配体。

研究设计与样本

  • ApoE-/-小鼠喂食致动脉粥样硬化饮食至20周(n=10),注射约200 pmol、约40 MBq的111In-DANBIRT后3小时行SPECT/CT显像。
  • 离体SPECT/CT显像、离体放射自显影、油红O脂质染色及组织学处理验证小鼠结果。
  • 人颈动脉内膜切除标本与约950 nmol、约190 MBq的111In-DANBIRT离体孵育2小时后行SPECT/CT及免疫组化分析。

主要发现

  • 所有动物主动脉弓均可见111In-DANBIRT局灶性摄取,平均靶本比1.7±0.5。
  • 离体SPECT/CT显像靶本比最高达11.5(范围2.6至11.5)。
  • 油红O脂质染色识别的斑块与离体放射自显影测定的111In-DANBIRT摄取共定位。
  • 组织学与离体放射自显影证实111In-DANBIRT摄取位于含CD68表达巨噬细胞和LFA-1表达炎症细胞的斑块区域。
  • 人颈动脉内膜切除标本离体孵育后SPECT/CT显示异质性斑块摄取,免疫组化显示摄取与CD68和LFA-1表达细胞共定位。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: 111In-DOTA-butylamino-NorBIRT (DANBIRT) is a novel radioligand which binds to Leukocyte Function-associated Antigen-1 (LFA-1), expressed on inflammatory cells. This study evaluated 111In-DANBIRT for the visualization of atherosclerotic plaque inflammation in mice. METHODS AND RESULTS: ApoE-/- mice, fed an atherogenic diet up to 20 weeks (n = 10), were imaged by SPECT/CT 3 hours post injection of 111In-DANBIRT (~ 200 pmol, ~ 40 MBq). Focal spots of 111In-DANBIRT were visible in the aortic arch of all animals, with an average Target-to-Background Ratio (TBR) of 1.7 ± 0.5. In vivo imaging results were validated by ex vivo SPECT/CT imaging, with a TBR up to 11.5 (range 2.6 to 11.5). Plaques, identified by Oil Red O lipid-staining on excised arteries, co-localized with 111In-DANBIRT uptake as determined by ex vivo autoradiography. Subsequent histological processing and in vitro autoradiography confirmed 111In-DANBIRT uptake at plaque areas containing CD68 expressing macrophages and LFA-1 expressing inflammatory cells. Ex vivo incubation of a human carotid endarterectomy specimen with 111In-DANBIRT (~ 950 nmol, ~ 190 MBq) for 2 hours showed heterogeneous plaque uptake on SPECT/CT, after which immunohistochemical analysis demonstrated co-localization of 111In-DANBIRT uptake and CD68 and LFA-1 expressing cells. CONCLUSIONS: Our results indicate the potential of radiolabeled DANBIRT as a relevant imaging radioligand for non-invasive evaluation of atherosclerotic inflammation.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Meester EJ, Krenning BJ, de Blois RH, et al. Imaging of atherosclerosis, targeting LFA-1 on inflammatory cells with 111In-DANBIRT. J Nucl Cardiol. 2018. PMID: 29536351. doi:10.1007/s12350-018-1244-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。